M&A Deal Summary

Perrigo Company Acquires J.B. Laboratories

On September 16, 2008, Perrigo Company acquired life science company J.B. Laboratories for 44M USD

Acquisition Highlights
  • This is Perrigo Company’s 3rd transaction in the Life Science sector.
  • This is Perrigo Company’s 18th largest (disclosed) transaction.
  • This is Perrigo Company’s 3rd transaction in the United States.
  • This is Perrigo Company’s 1st transaction in Michigan.

M&A Deal Summary

Date 2008-09-16
Target J.B. Laboratories
Sector Life Science
Buyer(s) Perrigo Company
Deal Type Add-on Acquisition
Deal Value 44M USD

Target

J.B. Laboratories

Holland, Michigan, United States
J.B. Laboratories was founded in 1978 under the guiding principals which distinguish our company in the contract pharmaceutical industry: commitment, quality and flexibility. J.B. Laboratories is 100% employee owned.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Perrigo Company

Dublin 2, Ireland

Category Company
Founded 1887
Sector Life Science
Employees9,140
Revenue 4.7B USD (2023)
DESCRIPTION
Entrance to a Perrigo facility in Duncan, South Carolina.
Entrance to a Perrigo facility in Duncan, South Carolina.

Perrigo Company is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and prescription (Rx) pharmaceuticals, nutritional products, and active pharmaceutical ingredients (API), as well as receives royalties from Multiple Sclerosis drug Tysabri®. The company is the world's largest manufacturer of OTC pharmaceutical products for the store brand market and an industry leader in pharmaceutical technologies. Perrigo Company was founded in 1887 and is based in Dublin, Ireland.


DEAL STATS #
Overall 7 of 31
Sector (Life Science) 3 of 7
Type (Add-on Acquisition) 6 of 23
State (Michigan) 1 of 2
Country (United States) 3 of 18
Year (2008) 2 of 4
Size (of disclosed) 18 of 23
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-01-09 Galpharm Healthcare

Barnsley, United Kingdom

Galpharm Healthcare Ltd. it the supplier of over-the-counter (OTC) store brand pharmaceutical products sold by super markets, drug stores and pharmacies in the U.K

Buy $86M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2008-10-06 Laboratorios Diba S.A.

Guadalajara, Mexico

Laboratorios Diba S.A. manufacture and market pharmaceutical products that contribute to health improvement, ensuring total satisfaction of customers and consumers, creating jobs and achieving collective and corporate profits.

Buy $25M